| Project/Area Number |
24590101
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Biological pharmacy
|
|---|
| Research Institution | Meiji Pharmaceutical University |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Renkei-kenkyūsha) |
ISHIDA Yo-ichi 明治薬科大学, 薬学部, 講師 (90510454)
|
|---|
| Project Period (FY) |
2012-04-01 – 2015-03-31
|
| Project Status |
Completed (Fiscal Year 2014)
|
| Budget Amount *help |
¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2014: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2013: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2012: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
|---|
| Keywords | リボソーム生合成 / リボソームRNA / シャペロン / AAA ATPase / RNA代謝 |
|---|
| Outline of Final Research Achievements |
A chaperone-like AAA-ATPase NVL2 acts on a pre-ribosomal particle during ribosome biogenesis in eukaryotic cells through interaction with an RNA helicase DOB1, and it participates in a remodeling of the molecular complex. In this study, we have analyzed an rRNA metabolic complex consisting of DOB1, RNA exosome, and other associating factors, which could be a possible target of NVL2.
As a result, presence of TRAMP-like complex consisting of DOB1, a poly(A) polymerase PAPD5, and an RNA-binding protein ZCCHC7 was confirmed in mammalian cells. Furthermore, we have shown a possibility that this complex is functions in the 3’-polyadenylation of nuclear RNAs including the rRNA precursors.
|
